Author: Alan Manevitz

Posted on

Work Place Violence

Technological advances (allowing employees and employers to be involved 24/7), economic issues (leading to less relative increases in salary) coupled with higher expectations of employers (for greater efficiency and productivity) have increased uncertainty, stress and anxiety in the workplace.  These and other factors contribute to a recent survey that demonstrated that one in every five Americans find their workplace to be hostile or threatening.   Dr. Manevitz was interviewed for a Daily Mail article on workplace hostility.

 

 

Posted on

Being Alan Manevitz, M.D.

Get to know one of the highest regarded Psychiatrists in the New York City metro area.

Born in Brooklyn, New York, nationally recognized Psychiatrist, Doctor Alan Manevitz, was destined to embrace a unique compassion for those who struggle with serious mental health issues.  He grew up as a young boy with a growing interest in medicine and would become a successful graduate of Columbia University College of Physicians and Surgeons in 1980.  He went on to complete his residency at the Payne Whitney Clinic of New York Hospital-Cornell Medical Center in 1984 where he subsequently completed an advanced pharmacology fellowship and sex therapy training in 1985.  Dr. Manevitz opened his own private practice in Manhattan, New York nearly three decades ago and embarked on a mission to fulfill his desire to treat those who struggled with mental illness.   Continue reading “Being Alan Manevitz, M.D.”

Posted on

Interview with WCBS-TV New York: New Study Links Antidepressants and Autism

According to Dr. Manevitz, it is critical to caution currently pregnant women who are on antidepressants who read about this study to not panic and suddenly discontinue their medication.  They could go through withdrawal symptoms that could be a higher risk than continuing on their medicine.  They should consult their obstetrician and psychiatrist before deciding anything. Every pregnancy needs to be considered individually for the risk benefit of treatment. While it is a cause for concern, the rates are still low.